Women with menopausal syndrome are administered 0.1 g once every 14-21 days, and for ovarian and breast cancer 100-200 mg after 8-14 days (long-term treatment is performed).
Abesifazane ebukhoneni menopausal syndrome iphathwa 0.1 g kanye ngosuku 14-21, futhi umdlavuza wesibeletho kanye webele - 100-200 mg zonke izinsuku 8-14 (ebibanjelwe lokhu kwelashwa eside).